VF Corp vs GeneDx Holdings Corp — how do they compare? VF Corp trades at $14.9 (market cap $5.81B), while GeneDx Holdings Corp trades at $81.98 (market cap $2.44B). The key difference: VF Corp is far larger — about 2.4× GeneDx Holdings Corp's market cap, and VF Corp pays a 2.44% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| VFC | WGS | |
|---|---|---|
Market Cap | $5.81B | $2.44B |
Sector | Consumer Cyclical | Technology |
52-Week High | $21.55 | $167.51 |
52-Week Low | $12.21 | $34.51 |
Enterprise Value | $10.09B | $2.48B |
Dividend Yield | 2.44% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx Holdings Corp. (WGS) trades at $77.08, up 10.76% today, showing strong momentum despite negative profitability metrics. The stock exhibits bullish technical signals with support at $72 and resistance at $80. Recent Q2 2026 earnings beat expectations with $0.01 EPS versus -$0.19 estimate, while revenue reached $114.4 million. However, the company faces significant challenges with a -23.4% net income margin and ongoing securities class action litigation.
Investment outlook remains cautiously optimistic given strong analyst support (90.9% buy rating) and $79.25 consensus price target. Key opportunities include growing genomic testing volumes and improved operational efficiency, while risks center on profitability challenges, legal liabilities, and high valuation multiples that may not justify current fundamentals.
Trailing returns across standard periods
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →